Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Interest Coverage Ratio (2019 - 2025)

Addex Therapeutics' Interest Coverage Ratio history spans 7 years, with the latest figure at 26.25 for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 85.7% to 26.25 in Q4 2025 year-over-year; TTM through Dec 2025 was 155.78, a 95.37% increase, with the full-year FY2025 number at 181.04, up 89.43% from a year prior.
  • Interest Coverage Ratio came in at 26.25 for Q4 2025, down from 852.11 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 1289.84 in Q1 2024, with the low at 183.53 in Q4 2024.
  • Historically, Interest Coverage Ratio has averaged 169.98 across 5 years, with a median of 22.85 in 2025.
  • Peak annual rise in Interest Coverage Ratio hit 36304.17% in 2024, while the deepest fall reached 1058.16% in 2024.
  • Year by year, Interest Coverage Ratio stood at 132.89 in 2021, then decreased by 12.85% to 149.98 in 2022, then skyrocketed by 89.43% to 15.85 in 2023, then crashed by 1058.16% to 183.53 in 2024, then surged by 85.7% to 26.25 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ADXN at 26.25 in Q4 2025, 852.11 in Q3 2025, and 125.75 in Q2 2025.